-
Mashup Score: 2
Light chain measurements form an essential component of the testing strategy for the detection and monitoring of patients with suspected and/or proven plasma cell disorders. Urine-based electrophoretic assays remain at the centre of the international guidelines for response assessment but the supplementary role of serum-free light chain (FLC) assays in response assessment and the detection of disease progression due to their increased sensitivity has been increasingly recognised since their introduction in 2001. Serum FLC assays have also been shown to be prognostic across the spectrum of plasma cell disorders and are now incorporated into risk stratification scores for patients with monoclonal gammopathy of undetermined significance (MGUS), smouldering multiple myeloma, and light chain amyloidosis (AL amyloidosis), as well as being incorporated into the criteria for defining symptomatic multiple myeloma. There are now multiple different commercially available serum FLC assays availabl
Source: www.mdpi.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
“I have distinct patients that stand out in my mind, I still remember them”, Orla McCourt said of her early years training as a physiotherapist. A clinical academic physiotherapist at University College London Hospital (UCLH), London, McCourt now specialises in physiotherapy for myeloma while conducting research for the UCL Cancer Institute. It is those early inpatients who were suffering side-effects from several lines of intensive treatment or surgery, as well as their illness itself, that have driven her to promote physiotherapy to be more pre-emptive rather than responsive.
Source: www.thelancet.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Interview: Cynthia Dunbar - 9 month(s) ago
Cynthia Dunbar – Secretary, American Society of Hematology (ASH); Chief, Translational Stem Cell Biology Branch, and Head, Molecular…
Source: www.emjreviews.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
EMJ Hematology 11.1 contains insightful interviews with leading experts in the field of blood disorders. We sat down with Cynthia Dunbar @cedunbar80 to discuss her research on molecular technologies. Read now 👉 https://t.co/6g8d2KsYYu #BloodDisorder #Haematology #OpenAccess https://t.co/kbCKLGoKst
-
-
Mashup Score: 0Not All in Vein: Rare Haematology Disorders Explained - 10 month(s) ago
Morag Griffin joins Jonathan Sackier to discuss rare diseases in haematology and the impact of vaccinations on these conditions.
Source: European Medical JournalCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2BSH at 60 - 10 month(s) ago
The first meeting of the British Society for Haematology (BSH) took place on 19 November 1960. For 60 years BSH has been dedicated to helping members support people with blood disorders and diseases. Our 60th anniversary is a time for recognising the breadth of roles within the multidisciplinary haematology team and acknowledging the contribution of haematology professionals to the advancement…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Tools of the trade - 10 month(s) ago
Discover some of the extraordinary tools of the trade that transformed the practice of haematology over five centuries. From Robert Hooke’s famous first description of a magnified cell, to trephines, needles, mouth pipetting and microscopes lit by candlelight – our anniversary stories explore the fascinating history of medicine for our specialty.
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1EHA 2023 — Highlights through a UK lens - 10 month(s) ago
Join the limbic as our expert panel present highlights from the EHA 2023 Annual Congress and discuss the possible impact of these updates on clinical practice in the UK. Hosted by Dr Graham Collins. Consultant haematologist, lymphoma lead and Associate Professor in Haematology at the Oxford Cancer and Haematology Centre. With special guests Dr Ceri […]
Source: thelimbic.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0BSH Crucible Prize: Interview with 2023 winner Dr Peter Johnstone - 10 month(s) ago
Crucible Prize winner 2023 Dr Peter Johnstone with Dr Richard Buka Crucible Prize winner 2022 The Crucible Prize is an innovative trainee-led initiative with a ÂŁ1000 prize. The theme for 2023 award was ‘What can haematology learn from history.’The five best abstracts were selected for oral presentation at the 63rd Annual Scientific which was held on 23-25 April 2023 at the ICC in Birmingham….
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Pushing the boundaries at the 2023 BSH ASM - 12 month(s) ago
The atmosphere at this year’s Annual Scientific Meeting (ASM) was a particularly energetic mix of excitement and anticipation, alongside some trenchant discussion of the challenges facing the haematology workforce. As nearly 1,600 delegates descended on the International Convention Centre (ICC) in Birmingham under dampish skies, there was a fair bit of side chatter about workloads and staffing…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Travel Scholarships - 1 year(s) ago
Deadline:31 January and 31 July annually Maximum value:ÂŁ1,000 What the scholarship covers:Reasonable accommodation, registration, travel and subsistence costs. If your destination is outside the UK, reasonable expenses are expected to align with gov.uk recommended rates. Please note: Applications to support attendance at ASH and EHA will not be considered under this scholarship, as they are…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Very interesting read @drKamarajk and @hannahvgiles đź‘Źđź‘Źđź‘Źđź‘Ź @UHNM_NHS #haematology colleagues Kam & Hannah have just had this published & it's definitely worth a read https://t.co/MK2iconQR4 https://t.co/D68P5LLfCF